Skip to main content
. 2009 Oct 21;90(6):1532–1540. doi: 10.3945/ajcn.2009.28285

TABLE 6.

Summary of urine and serum biochemical measures at baseline and at the end of the 2 study periods1

Baseline Low-normal pH High-normal pH P value2
Final arterial pH 7.37 ± 0.013 7.44 ± 0.02 <0.001
Urine volume (mL/d)4 16.9 (84.4)5 41.1 (335.3) 0.03
Urinary urea nitrogen (mg/d)4 15.3 (129.5) 78.2 (668.3) 0.25
Urinary urea clearance (mL/min)4 0.02 (0.14) 0.09 (1.02) 0.03
Urinary creatinine clearance (mL/min)4 0.08 (0.51) 0.16 (1.4) 0.35
Urine protein excretion (mg/d)4 47 (143) 148 (457) 0.12
Venous bicarbonate (mEq/L) 23.0 ± 2.6 18.9 ± 2.2 24.6 ± 2.6 0.002
Arterial pCO2 (mm Hg) 37.5 ± 3.6 35.9 ± 3.0 41.8 ± 3.7 0.001
Serum urea nitrogen (mg/dL) 55.0 ± 17.1 64.4 ± 20.2 54.1 ± 13.7 0.01
Serum creatinine (mg/dL) 13.7 ± 4.6 13.6 ± 4.1 12.9 ± 3.5 0.18
Serum potassium (mEq/L) 4.2 ± 0.8 4.3 ± 0.7 3.9 ± 0.8 0.28
Serum phosphorus (mg/dL) 6.3 ± 1.8 5.7 ± 1.2 5.5 ± 1.1 0.48
Serum parathyroid hormone (pg/mL)6 337 (273) 224 (242) 318 (252) 0.21
Serum albumin (g/dL)6 3.5 ± 0.6 3.1 ± 0.4 3.1 ± 0.4 0.12
Serum prealbumin (g/dL) 44.7 ± 10.6 40.7 ± 9.5 39.9 ± 7.5 0.72
Serum transferrin (mg/dL) 233.5 ± 57.8 206.6 ± 35.2 217.0 ± 73.8 0.57
Serum insulin-like growth factor I (μg/L) 192 (143) 189 (173) 159 (191) 0.89
Serum C-reactive protein (mg/L) 3.2 ± 2.7 2.1 ± 1.4 1.8 ± 1.2 0.37
Serum tumor necrosis factor (pg/mL) 5.8 ± 1.7 6.4 ± 1.8 5.5 ± 1.3 0.09
Serum interleukin-6 (pg/mL) 3.8 ± 2.1 3.3 ± 1.8 2.6 ± 1.3 0.09
1

pCO2, partial pressure of carbon dioxide.

2

Significance of difference (end of low-normal and high-normal pH phases) between means tested by paired t test and between medians by Wilcoxon's signed-rank test.

3

Mean ± SD (all such values).

4

Values are the means for the last 5 d of each phase; 6 of the 8 study subjects had measurable urine outputs.

5

Median; interquartile range in parentheses (all such values).

6

Measured by using bromocresol purple during the inpatient phase of the study.